Haemophilia A: meeting the needs of individual patients. - Wikidata - awgldk - TriplyDB

Haemophilia A: meeting the needs of individual patients.

Haemophilia A: meeting the needs of individual patients.

http://www.wikidata.org/entity/Q37008132

about

The group medical appointment (GMA) in haemophilia and von Willebrand's disease: a new development in outpatient paediatric care.Therapeutic use of arteriovenous fistula in children with haemophilia.

P2860

Q39635167-F5E2ABBB-41F7-45B4-AB58-853A1CEFCF8B Q45881732-57C2B777-A769-4DF5-95DF-01BB58BB8378

P2860

Haemophilia A: meeting the needs of individual patients.

http://www.wikidata.org/entity/Q37008132

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Haemophilia A: meeting the needs of individual patients.

@en

Haemophilia A: meeting the needs of individual patients.

@nl

type

label

Haemophilia A: meeting the needs of individual patients.

@en

Haemophilia A: meeting the needs of individual patients.

@nl

prefLabel

Haemophilia A: meeting the needs of individual patients.

@en

Haemophilia A: meeting the needs of individual patients.

@nl

P1433

Q37008132-495301E8-0C7B-4624-AFB4-4D1C4F2A6F53

P1476

Q37008132-EF3B2338-762C-4EEE-97B8-DA90117A6014

P2093

Q37008132-700684B9-DDF8-4F4D-8B63-401A1B391030

Q37008132-A074B193-8B6A-4D0A-81B6-7C3AC1D11D42

P2860

Q37008132-0CB62B7A-00B6-4554-ACA0-9BEB8CCAEF9C

Q37008132-0ED6D951-109D-47CB-9FFD-2B4CA6E8BE7E

Q37008132-173E848C-E412-4FC8-915E-B7DE7A083CA3

Q37008132-17E64A92-6549-44CF-A80C-0FB29F97CF1E

Q37008132-234F9EF9-706B-4BBC-BD37-FC1D46C3DC52

Q37008132-2DA786AA-2312-4DA7-A574-FE148F8A17C0

Q37008132-32E18147-B3DC-4CC3-AB5A-4A152F544AAC

Q37008132-4486FCB4-825A-49D5-9C89-0560E387C035

Q37008132-49692287-1DE6-4F24-A941-625335D82081

Q37008132-49FB07B2-CF44-4975-8B62-8527894870F1

P304

Q37008132-EB218C4B-577A-4CFF-AF2A-5126988A1FBE

P31

Q37008132-E5BAF04C-2BBA-4D3F-98C6-482F7EE2DED3

P356

Q37008132-B58C29DC-38A5-4561-A69C-B4792917841C

P433

Q37008132-E4F95CAA-0F9A-418C-9B28-1362E75D1AFF

P478

Q37008132-F1052E1D-BECF-421B-A04D-7C0F229E0CF0

P577

Q37008132-C946302C-43DF-4447-8462-88741489B9F3

P698

Q37008132-E7AD0545-0C06-4EBB-9C83-A1205C0AAA22

P921

Q37008132-34DE41D9-AEDC-4271-8E30-B6A88A266A00

Q37008132-FB05D410-6DA7-46A0-AA50-78A2068D15AA

P356

BJON.2007.16.16.27077

P1433

British Journal of Nursing

P1476

Haemophilia A: meeting the needs of individual patients.

@en

P2093

Kate Khair

http://www.w3.org/2001/XMLSchema#string

Susan J Geraghty

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy.

The hemophilias--from royal genes to gene therapy.

Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII.

Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies.

Inhibitors: resolving diagnostic and therapeutic dilemmas.

The overall effectiveness of prophylaxis in severe haemophilia.

Health-related quality of life as outcome parameter in haemophilia treatment.

Economics of prophylactic treatment.

Treating haemophilia A with recombinant blood factors: a comparison.

Consensus recommendations for use of central venous access devices in haemophilia.

P304

987-993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12968/BJON.2007.16.16.27077

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18026037

http://www.w3.org/2001/XMLSchema#string

P921